Enliven Therapeutics, Inc. (ELVN) — Insider Trading

Insider trading activity for Enliven Therapeutics, Inc. sourced from SEC EDGAR Form 4 filings.

Overview

ORBIMED ADVISORS LLC — 6 trades, buy: $0, sell: $51.7M
Collins Helen Louise (CHIEF MEDICAL OFFICER) — 28 trades, buy: $12K, sell: $2.7M
Hohl Benjamin (CHIEF FINANCIAL OFFICER) — 11 trades, buy: $0, sell: $919K
Kunkel Lori Anne — 5 trades, buy: $0, sell: $850K

Date	Insider	Ticker / Company	Type	Shares	Value
Sep 17, 2026	Collins Helen Louise	ELVN Enliven Therapeutics, Inc.	OTHER	5,000	N/A
Sep 17, 2026	Collins Helen Louise	ELVN Enliven Therapeutics, Inc.	SELL	240	$12K
Sep 17, 2026	Collins Helen Louise	ELVN Enliven Therapeutics, Inc.	SELL	1,844	$94K
Sep 17, 2026	Collins Helen Louise	ELVN Enliven Therapeutics, Inc.	SELL	2,916	$146K
Sep 17, 2026	Collins Helen Louise	ELVN Enliven Therapeutics, Inc.	OTHER	5,000	$12K
Sep 17, 2026	Hohl Benjamin	ELVN Enliven Therapeutics, Inc.	OTHER	3,982	N/A
Sep 17, 2026	Hohl Benjamin	ELVN Enliven Therapeutics, Inc.	SELL	289	$15K
Sep 17, 2026	Hohl Benjamin	ELVN Enliven Therapeutics, Inc.	SELL	2,194	$111K
Sep 17, 2026	Hohl Benjamin	ELVN Enliven Therapeutics, Inc.	SELL	3,535	$177K
Sep 17, 2026	Hohl Benjamin	ELVN Enliven Therapeutics, Inc.	OTHER	3,982	$59K
Aug 17, 2026	Collins Helen Louise	EELVN EELVN	SELL	5,000	$293K
Aug 17, 2026	Collins Helen Louise	EELVN EELVN	BUY	5,000	$12K
Aug 17, 2026	Hohl Benjamin	EELVN EELVN	SELL	6,018	$353K
Jul 6, 2026	Kunkel Lori Anne	ELVN Enliven Therapeutics, Inc.	SELL	5,889	$299K
Jul 6, 2026	Kunkel Lori Anne	ELVN Enliven Therapeutics, Inc.	SELL	4,111	$205K
Jun 22, 2026	ORBIMED ADVISORS LLC	ELVN Enliven Therapeutics, Inc.	SELL	46,776	$2.1M
Jun 22, 2026	ORBIMED ADVISORS LLC	ELVN Enliven Therapeutics, Inc.	SELL	787,024	$35.7M
Jun 22, 2026	ORBIMED ADVISORS LLC	ELVN Enliven Therapeutics, Inc.	SELL	1,477	$66K
Jun 22, 2026	ORBIMED ADVISORS LLC	ELVN Enliven Therapeutics, Inc.	SELL	24,846	$1.1M
Jun 17, 2026	Collins Helen Louise	ELVN Enliven Therapeutics, Inc.	OTHER	5,000	N/A